News archive search
Search the Newsreel
Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.
- Showing
- 37–72
- Matches
- 235
- Sources here
- 18
- Companies here
- 9
Active search
235 matching headlines
Search results
Matching headlines
External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.
Wasatch Advisors LP Decreases Stock Position in Hawkins, Inc. $HWKN
Wasatch Advisors LP reduced its stake in Hawkins, Inc. by 17.1% in the second quarter, selling 80,157 shares and retaining 389,515 shares valued at $55.35 million. Despite mixed analyst ratings, the company has an average "Hold" rating and a consensus price target of $171, …
Quantinno Capital Management LP Cuts Stock Position in Hawkins, Inc. $HWKN
Quantinno Capital Management LP significantly reduced its stake in Hawkins, Inc. by 45.4% in the first quarter, selling 9,320 shares and retaining 11,196 shares valued at $1.72 million. Other institutional investors also adjusted their positions in the specialty chemicals company. Analyst ratings are mixed, …
Hawkins Inc CEO Patrick H. Hawkins Transfers 580 Shares as Gift, Updates Ownership Details
Patrick H. Hawkins, CEO and President of Hawkins Inc., recently filed a Form 4 detailing a gift of 580 shares of common stock on August 7, 2026. This transaction also included updated figures for his beneficial ownership in the company. The article briefly notes …
Hawkins Inc. (HWKN) CEO gifts 580 shares, retains over 321K direct
Hawkins Inc.'s CEO and President, Patrick H. Hawkins, reported a bona fide gift of 580 shares of common stock on August 7, 2026, for no consideration. Following this transaction, he directly holds 321,257.0494 shares and indirectly holds 26,084.9395 shares through an ESOP trustee. The …
Sales Edge Higher As Earnings Slip Might Change The Case For Investing In Hawkins (HWKN)
Hawkins, Inc. (HWKN) reported a sales increase to US$315.68 million in Q1 2026, up from US$293.27 million a year earlier, but net income and diluted EPS slightly decreased. Despite the earnings slip, the company raised its quarterly dividend by 5% and completed a share …
Kopp Family Office LLC Sells 15,321 Shares of Hawkins, Inc. $HWKN
Kopp Family Office LLC significantly reduced its stake in Hawkins, Inc. (NASDAQ:HWKN) by 56.8% in the second quarter, selling 15,321 shares and retaining 11,636 shares valued at $1.65 million. Despite this, institutional investors still collectively own 69.71% of the company. Analyst sentiment is mixed, …
Hawkeye 360 Inc (HAWK:UN): Stock Price, Quote and News
This article provides a listing for Hawkeye 360 Inc (HAWK:UN), offering information on its stock price, quotes, and related news. It appears to be a placeholder or a link to a company profile page on BNN Bloomberg, as no specific news content is present. …
AXTA or HWKN: Which Is the Better Value Stock Right Now?
Investors interested in Chemical - Specialty stocks are likely familiar with Axalta Coating Systems (AXTA) and Hawkins (HWKN). But which of these two stocks is more attractive to value investors? We'll need to take a closer look to find out. We have found that …
Defense Stocks Investors Are Watching As Security Spending Comes Back Into Focus
As concerns about political instability and security spending increase, investors are focusing on defense and security stocks. This article highlights three companies – HawkEye 360 (HAWK), Senior (SNR), and Satellogic (SATL) – that are particularly exposed to the current news cycle, each presenting a …
Mohawk Industries, Inc. (MHK) Stock Forecasts
Argus has upgraded Mohawk Industries, Inc. (MHK) to a HOLD rating. Mohawk Industries manufactures various flooring products, including carpets, rugs, ceramic, laminate, and luxury vinyl tile. The report provides a summary of the company, its current price, and price target.
Whitehawk Therapeutics (NASDAQ:WHWK) Rating Increased to Hold at Wall Street Zen
Wall Street Zen has upgraded Whitehawk Therapeutics (NASDAQ:WHWK) from a "sell" to a "hold" rating. Despite this upgrade, the overall analyst consensus for WHWK remains a "Moderate Buy" with an average price target of $8.20. The company recently reported a quarterly loss of $0.20 …
Hawkins Inc (HWKN) Q3 2026 Earnings Report - Results, Call & Slides
Hawkins Inc (HWKN) reported its Q3 2026 earnings, missing both EPS and revenue expectations. The company posted an actual EPS of $0.69 against a consensus of $0.74, and actual revenue of $244.08 million compared to an expected $252.51 million, though revenue did see a …
This Insider Has Just Sold Shares In Mohawk Industries
Mohawk Industries' CEO & Chairman, Jeffrey Lorberbaum, recently sold US$7.8 million worth of stock at US$132 per share, reducing his holding by 0.6%. While this was the largest insider sale in the last year, it occurred at the current stock price, which is less …
Earnings Preview: HawkEye 360 to Report Financial Results Post-market on August 13
This article announces that HawkEye 360 will report its financial results post-market on August 13. It is an earnings preview indicating an upcoming financial disclosure by the company.
Whitehawk Therapeutics 2Q Research and Development Expenses $12.9M >WHWK
Whitehawk Therapeutics reported its second-quarter research and development expenses totaling $12.9 million. This financial update is relevant for investors tracking the company's operational expenditures, particularly in its core therapeutic development activities. The disclosed figure provides insight into Whitehawk's ongoing investment in advancing its pipeline.
Hawkins executives to participate in virtual investor event Aug. 18
Hawkins, Inc. (Nasdaq: HWKN) announced that CEO Patrick Hawkins and CFO Jeff Oldenkamp will participate in Seaport Research Partners’ 15th Annual Summer Investor Conference, a virtual event held August 18–19, 2026. Hawkins executives will engage in one-on-one and small group meetings with institutional investors …
Hawkins, Inc. to Participate in Seaport Research Partners’ 15th Annual Summer Investor Conference
ROSEVILLE, Minn., Aug. 07, 2026 (GLOBE NEWSWIRE) -- Hawkins, Inc. (Nasdaq: HWKN), a leading water treatment and specialty ingredients company, today announced that Patrick Hawkins, Chief Executive Officer, and Jeff Oldenkamp, Chief Financial Officer, will participate in Seaport Research Partners’ 15th Annual Summer Investor …
State Street (NYSE: STT) discloses 5.1% beneficial stake in Hawkins Inc. (HWKN)
State Street Corporation has reported a 5.1% beneficial ownership stake in Hawkins Inc. (HWKN) common stock, totaling 1,061,843 shares. This passive investment, managed through various State Street Global Advisors affiliates, indicates shared voting and dispositive power over the shares on behalf of underlying clients. …
Mohawk Industries Director Trades $1.81M In Company Stock
Mohawk Industries Director Bernard Thiers sold 13,393 shares of the company stock for a total of $1,807,787, according to an SEC filing on August 6. The company shows strong revenue growth and EPS, along with healthy debt management, despite a low gross margin. Its …
Wilsey Asset Management Inc. Grows Position in Mohawk Industries, Inc. $MHK
Wilsey Asset Management Inc. increased its stake in Mohawk Industries (NYSE:MHK) by 3.6% in the second quarter, bringing its total holdings to 313,981 shares valued at approximately $38.1 million. This increase follows Mohawk's strong quarterly results, which surpassed analyst expectations with EPS of $3.67 …
Whitehawk Therapeutics 2Q 2026: Revenue $0 Net loss $16.64M, EPS $(0.20) — 10-Q Summary
Whitehawk Therapeutics reported its second-quarter 2026 results, showing no product revenue and a net loss of $16.64 million, or $(0.20) per diluted share. This marks an improvement from the $52.62 million net loss in the year-ago quarter. The company has refocused on ADC research …
MOHAWK INDUSTRIES INC SEC Filing (Aug 6, 2026)
This article reports on an SEC Form 144 filing by MOHAWK INDUSTRIES INC (MHK) on August 6, 2026. The filing indicates a proposed sale of 13,393 shares of common stock with an aggregate market value of $1,807,753.17, acquired through the exercise of options under …
Form 8K Whitehawk Therapeutics Inc For: 6 August By Investing.com
The article reports that Whitehawk Therapeutics Inc. filed a Form 8K on August 6, 2026. This filing is a standard requirement by the SEC for companies to announce major events that shareholders should know about. The article provides the filing date and company name, …
Mohawk Industries Inc. stock underperforms Thursday when compared to competitors
Mohawk Industries Inc. (MHK) stock dropped 2.41% on Thursday, closing at $132.42, underperforming the broader market. This marked the second consecutive day of losses for the company, as the S&P 500 Index fell 0.18% and the Dow Jones Industrial Average dropped 0.85%.
Whitehawk Therapeutics, Inc. (WHWK) Stock Price, News, Quote & History
This Yahoo Finance page provides comprehensive information on Whitehawk Therapeutics, Inc. (WHWK), a clinical-stage oncology therapeutics company. It includes real-time stock price data, historical performance, key financial metrics, company overview, recent news, analyst insights, and comparison tools with similar biotechnology companies. The stock showed …
Whitehawk Therapeutics reports Q2 2026 net loss $16.6M; cash $190.0M funds into 2H 2028
Whitehawk Therapeutics reported a Q2 2026 net loss of $16.6 million, a significant reduction from the $52.6 million loss in Q2 2025. The company held $190.0 million in cash, cash equivalents, and short-term investments as of June 30, 2026, which is expected to fund …